| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data
|
Liu, Yi-Chun Carol
|
|
|
41 |
11 |
p. 1902-1910
|
artikel
|
| 2 |
Comparative performance of between-population vaccine allocation strategies with applications for emerging pandemics
|
Joshi, Keya
|
|
|
41 |
11 |
p. 1864-1874
|
artikel
|
| 3 |
Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis
|
Wankhede, Durgesh
|
|
|
41 |
11 |
p. 1791-1798
|
artikel
|
| 4 |
Development of in ovo-compatible NS1-truncated live attenuated influenza vaccines by modulation of hemagglutinin cleavage and polymerase acidic X frameshifting sites
|
Ghorbani, Amir
|
|
|
41 |
11 |
p. 1848-1858
|
artikel
|
| 5 |
Editorial Board/Aims and Scope
|
|
|
|
41 |
11 |
p. IFC
|
artikel
|
| 6 |
Evaluation of cross-protection between S. Pneumoniae serotypes 35B and 29 in a mouse model
|
Kim, Ellie
|
|
|
41 |
11 |
p. 1774-1777
|
artikel
|
| 7 |
Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study
|
Buntinx, Erik
|
|
|
41 |
11 |
p. 1875-1884
|
artikel
|
| 8 |
Incident autoimmune conditions among males receiving quadrivalent human papillomavirus vaccine in the United States
|
Seeger, John D.
|
|
|
41 |
11 |
p. 1826-1833
|
artikel
|
| 9 |
Meeting Summary: Global Vaccine and Immunization Research Forum, 2021
|
Ford, Andrew
|
|
|
41 |
11 |
p. 1799-1807
|
artikel
|
| 10 |
Persistent SARS-COV-2 infection in vaccinated individual with three doses of COVID-19 vaccine
|
Silva Vasconcelos, Germana
|
|
|
41 |
11 |
p. 1778-1782
|
artikel
|
| 11 |
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis
|
Watanabe, Atsuyuki
|
|
|
41 |
11 |
p. 1783-1790
|
artikel
|
| 12 |
Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants
|
Kwak, Hye Won
|
|
|
41 |
11 |
p. 1892-1901
|
artikel
|
| 13 |
Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults
|
Sonoyama, Takuhiro
|
|
|
41 |
11 |
p. 1834-1847
|
artikel
|
| 14 |
Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021–June 30, 2022
|
Moro, Pedro L.
|
|
|
41 |
11 |
p. 1859-1863
|
artikel
|
| 15 |
Safety of 9-valent human papillomavirus vaccine administered to males and females in routine use
|
Hansen, John
|
|
|
41 |
11 |
p. 1819-1825
|
artikel
|
| 16 |
SARS-CoV-2 viral shedding in vaccinated and unvaccinated persons: A case series
|
McCormick, David W.
|
|
|
41 |
11 |
p. 1769-1773
|
artikel
|
| 17 |
The societal value of SARS-CoV-2 booster vaccination in Indonesia
|
Johnson, Rob
|
|
|
41 |
11 |
p. 1885-1891
|
artikel
|
| 18 |
Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July—August 2021
|
Salvatore, Phillip P.
|
|
|
41 |
11 |
p. 1808-1818
|
artikel
|
Tijdschrift beschrijving